Nipro : Notice of Trade Name Change of Medical Device Subsidiary in the Republic of Korea

April 17, 2025

NIPRO CORPORATION

Notice of Trade Name Change of

Medical Device Subsidiary in the Republic of Korea

NIPRO CORPORATION is pleased to announce that one of its subsidiaries, Nipro Dongduk Medical Corporation (Head office: Seoul, Republic of Korea; hereinafter "Nipro Dongduk"), changed its trade name to NIPRO MEDICAL KOREA CORPORATION on March 26, 2025.

Since acquiring shares in 2015, NIPRO has been engaged in the sale of medical devices, including dialyzers and dialysis machines, in the Republic of Korea through Nipro Dongduk. With this trade name change, NIPRO aims to further enhance the presence of the NIPRO brand and expand its market share. In addition, to strengthen its competitiveness in the market by offering comprehensive dialysis-related products, NIPRO plans to newly obtain a pharmaceutical wholesale license and add pharmaceuticals such as dialysis solutions and cleaning agents to its product lineup.

Under this new trade name, the NIPRO Group will continue to provide community-based, attentive services while striving to meet the needs of the medical treatment front line while also further expanding the company's business activities around the world.

Subsidiary Overview

(1) Trade name: NIPRO MEDICAL KOREA CORPORATION

1. Location: Seoul, Republic of Korea
2. Date of trade name change: March 26, 2025
3. Description of business: Sales of medical devices
4. Shareholding ratio: 33.33%

Map taken from http://www.craftmap.box-i.net/

This news release is meant to provide information on NIPRO's corporate activities and an overview of our initiatives to not only the press but also our many stakeholders, including shareholders and investors in a fair and timely manner.

The information about NIPRO products and services included in this release is not intended for use in attracting customers or as medical advice.

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.